# AMP-BPT and His-BPT for Assessment of Asthma

> **NCT02318043** · NA · COMPLETED · sponsor: **Guangzhou Institute of Respiratory Disease** · enrollment: 84 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** inhaled corticosteroids (usually budesonide/fomorterol 160/4.5mcg; fluticasone/salmeterol 250/50mcg)

## Key facts

- **NCT ID:** NCT02318043
- **Lead sponsor:** Guangzhou Institute of Respiratory Disease
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2014-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02318043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02318043, "AMP-BPT and His-BPT for Assessment of Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02318043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*